Current Diabetes Reviews

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back Subscribe
Research Article

Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain

Author(s): Ana Cristina Ravazzani de Almeida Fariaorcid of author, Joceline Franco Dall'Agnolorcid of author, Aline Maciel Gouveiaorcid of author, Clara Inácio De Paivaorcid of author, Victoria Chechetto Segallaorcid of author, Fernando Eiji Ogataorcid of author and Cristina Pellegrino Baena*

Volume 19, Issue 9, 2023

Published on: 18 October, 2022

Article ID: e050822207323

Pages: 9

DOI: 10.2174/1573399819666220805154638

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: Diabetic retinopathy (DR) is a chronic diabetes complication. People with Type 2 Diabetes Mellitus (T2DM) have two times the risk for dementia, suggesting it is a new chronic diabetes complication.

Objective: Evaluate the association of DR with cognitive performance in a T2DM population.

Methods: Cross-sectional study with 400 T2DM adults from whom socio-demographic, clinical, laboratory data were collected, and screening test for depression symptoms (Patient Health Questionaire- 9 (PHQ-9)), Mini-Mental State Examination (MMSE), Semantic Verbal Fluency Test, Trail Making Test A and B, Word Memory test were performed. All cognitive test scores were converted into Global Cognition z-Score (GCS(z)). The association between GCS(z) < 0 with DR was performed using a multivariate binary logistic regression model adjusted for age ≥ 65 years, school years ≤ 6 years, DM duration ≥ 10 years, depression symptoms score > 9 at PHQ-9, arterial hypertension, physical activity, diabetic retinopathy, macular edema, and cardiovascular disease.

Results: After exclusions, the 251 eligible patients were 56.6% female, with a mean age of 61.1 (±9.8) years, DM duration of 12.6 (±8.9) years, and 7.6 (±4.2) years of school education. DR prevalence was 46.5%. Multivariate Logistic Regression Model showed an association between DR and GCS(z) < 0, with odds ratio (CI95%) of 2.50 (1.18-5.34), adjusted for age, low education level, arterial hypertension and depression symptoms (OD and CI95% respectively: 5.46(2.42-12.34); 12.19 (5.62-26.46); 2.55 (0.88-7.39); 3.53 (1.55-8.07)).

Conclusion: In this T2DM population, having DR increased the chance for worse cognitive performance even when adjusted for age, low education level, presence of arterial hypertension, and depression symptoms.

Keywords: Diabetic retinopathy, cognitive dysfunction, type 2 diabetes mellitus, risk factors, dementia, cognitive decline.

[1]
Prince MJ, Wimo A, Guerchet MM, Ali GC, Wu Y-T, Prina M. World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. London: Alzheimer's Disease International 2015.
[2]
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1204-22.
[http://dx.doi.org/10.1016/S0140-6736(20)30925-9] [PMID: 33069326]
[3]
nternational Diabetes Federation. IDF Diabetes Atlas 9th ed. 2019. Available from: https://www.diabetesatlas.org
[4]
Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35(3): 556-64.
[http://dx.doi.org/10.2337/dc11-1909] [PMID: 22301125]
[5]
Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999; 53(9): 1937-42.
[http://dx.doi.org/10.1212/WNL.53.9.1937] [PMID: 10599761]
[6]
Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002; 51(4): 1256-62.
[http://dx.doi.org/10.2337/diabetes.51.4.1256] [PMID: 11916953]
[7]
Rawlings AM, Sharrett AR, Schneider ALC, et al. Diabetes in midlife and cognitive change over 20 years: A cohort study. Ann Intern Med 2014; 161(11): 785-93.
[http://dx.doi.org/10.7326/M14-0737] [PMID: 25437406]
[8]
Roberts RO, Knopman DS, Geda YE, et al. Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 2014; 10(1): 18-26.
[http://dx.doi.org/10.1016/j.jalz.2013.01.001] [PMID: 23562428]
[9]
Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011; 10(9): 819-28.
[http://dx.doi.org/10.1016/S1474-4422(11)70072-2] [PMID: 21775213]
[10]
Munshi MN. Cognitive dysfunction in older adults with diabetes: What a clinician needs to know. Diabetes Care 2017; 40(4): 461-7.
[http://dx.doi.org/10.2337/dc16-1229] [PMID: 28325796]
[11]
Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005; 48(12): 2460-9.
[http://dx.doi.org/10.1007/s00125-005-0023-4] [PMID: 16283246]
[12]
Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract 2017; 124: 41-7.
[http://dx.doi.org/10.1016/j.diabres.2016.10.024] [PMID: 28088029]
[13]
Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig 2013; 4(6): 640-50.
[http://dx.doi.org/10.1111/jdi.12087] [PMID: 24843720]
[14]
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 2006; 5(1): 64-74.
[http://dx.doi.org/10.1016/S1474-4422(05)70284-2] [PMID: 16361024]
[15]
Simó R, Ciudin A, Simó-Servat O, Hernández C. Cognitive impairment and dementia: A new emerging complication of type 2 diabetes-The diabetologist’s perspective. Acta Diabetol 2017; 54(5): 417-24.
[http://dx.doi.org/10.1007/s00592-017-0970-5] [PMID: 28210868]
[16]
Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement 2014; 10(1) (Suppl.): S76-83.
[http://dx.doi.org/10.1016/j.jalz.2013.12.010] [PMID: 24529528]
[17]
van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 2020; 8(4): 325-36.
[http://dx.doi.org/10.1016/S2213-8587(19)30405-X] [PMID: 32135131]
[18]
Heringa SM, Bouvy WH, van den Berg E, Moll AC, Kappelle LJ, Biessels GJ. Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: A systematic review. J Cereb Blood Flow Metab 2013; 33(7): 983-95.
[http://dx.doi.org/10.1038/jcbfm.2013.58] [PMID: 23591648]
[19]
Crosby-Nwaobi RR, Sivaprasad S, Amiel S, Forbes A. The relationship between diabetic retinopathy and cognitive impairment. Diabetes Care 2013; 36(10): 3177-86.
[http://dx.doi.org/10.2337/dc12-2141] [PMID: 23633523]
[20]
Fickweiler W, Wolfson EA, Paniagua SM, et al. Association of cognitive function and retinal neural and vascular structure in type 1 diabetes. J Clin Endocrinol Metab 2021; 106(4): 1139-49.
[http://dx.doi.org/10.1210/clinem/dgaa921] [PMID: 33378459]
[21]
Exalto LG, Biessels GJ, Karter AJ, Huang ES, Quesenberry CP, Whitmer RA. Severe diabetic retinal disease and dementia risk in type 2 diabetes. J Alzheimers Dis 2014; 42 Suppl 3(03): S109-17.
[http://dx.doi.org/10.3233/JAD-132570] [PMID: 24625797]
[22]
Cheng D, Zhao X, Yang S, Wang G, Ning G. Association between diabetic retinopathy and cognitive impairment: A systematic review and meta-analysis. Front Aging Neurosci 2021; 13: 692911.
[http://dx.doi.org/10.3389/fnagi.2021.692911] [PMID: 34276346]
[23]
Mutlu U, Bonnemaijer PWM, Ikram MA, et al. Retinal neurodegeneration and brain MRI markers: The Rotterdam study. Neurobiol Aging 2017; 60: 183-91.
[http://dx.doi.org/10.1016/j.neurobiolaging.2017.09.003] [PMID: 28974335]
[24]
Gasecka A, Siwik D, Gajewska M, et al. Early biomarkers of neurodegenerative and neurovascular disorders in diabetes. J Clin Med 2020; 9(9): 2807.
[http://dx.doi.org/10.3390/jcm9092807] [PMID: 32872672]
[25]
Diretrizes da Sociedade Brasileira de Diabetes Mellitus 2017– 2018. In. São Paulo, Brasil: Clannad Editora Científica; 2017. Available from: https://diabetes. orgbr/ebook/ diretrizes-dasociedade- brasileira-de-diabetes-2017- 2018/
[26]
World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2013; 310(20): 2191-4.
[http://dx.doi.org/10.1001/jama.2013.281053] [PMID: 24141714]
[27]
Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: A report of a workgroup of the American diabetes association and the endocrine society. Diabetes Care 2013; 36(5): 1384-95.
[http://dx.doi.org/10.2337/dc12-2480] [PMID: 23589542]
[28]
Barroso WKS, Rodrigues CIS, Bortolotto LA, et al. Brazilian Guidelines of Hypertension - 2020. Arq Bras Cardiol 2021; 116(3): 516-658.
[http://dx.doi.org/10.36660/abc.20201238] [PMID: 33909761]
[29]
Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: A review. Clin Exp Ophthalmol 2016; 44(4): 260-77.
[http://dx.doi.org/10.1111/ceo.12696] [PMID: 26716602]
[30]
Wilkinson CP, Ferris FL III, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110(9): 1677-82.
[http://dx.doi.org/10.1016/S0161-6420(03)00475-5] [PMID: 13129861]
[31]
Zanocco JA, Nishida SK, Passos MT, et al. Race adjustment for estimating glomerular filtration rate is not always necessary. Nephron Extra 2012; 2(1): 293-302.
[http://dx.doi.org/10.1159/000343899] [PMID: 23243414]
[32]
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9): 604-12.
[http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006] [PMID: 19414839]
[33]
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease. Nephrology and Dialysis 2021; 23(2) (Suppl.): 9-121.
[34]
Mastrocola LE, Amorim BJ, Vitola JV, et al. Update of the Brazilian Guideline on Nuclear Cardiology - 2020. Arq Bras Cardiol 2020; 114(2): 325-429.
[PMID: 32215507]
[35]
Campanholo KR, Romão MA, Machado MAR, et al. Performance of an adult Brazilian sample on the Trail Making Test and Stroop Test. Dement Neuropsychol 2014; 8(1): 26-31.
[http://dx.doi.org/10.1590/S1980-57642014DN81000005] [PMID: 29213876]
[36]
Hamdan AC, Hamdan EMLR. Effects of age and education level on the Trail Making Test in a healthy Brazilian sample. Psychol Neurosci 2009; 2(2): 199-203.
[http://dx.doi.org/10.3922/j.psns.2009.2.012]
[37]
Pavão Martins I, Maruta C, Freitas V, Mares I. Executive performance in older Portuguese adults with low education. Clin Neuropsychol 2013; 27(3): 410-25.
[http://dx.doi.org/10.1080/13854046.2012.748094] [PMID: 23259850]
[38]
Nitrini R, Caramelli P, Bottino CM de C, Damasceno BP, Brucki SM, Anghinah R. Diagnosis of alzheimer’s disease in Brazil: cognitive and functional evaluation. Recommendations of the scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Arq Neuropsiquiatr 2005; 63(3A): 720-7.
[http://dx.doi.org/10.1590/S0004-282X2005000400034] [PMID: 16172733]
[39]
Bertolucci PHF, Okamoto IH, Brucki SMD, Siviero MO, Toniolo Neto J, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 2001; 59(3-A): 532-6.
[http://dx.doi.org/10.1590/S0004-282X2001000400009] [PMID: 11588630]
[40]
Fillenbaum GG, van Belle G, Morris JC, et al. Consortium to establish a registry for Alzheimer’s disease (CERAD): The first twenty years. Alzheimers Dement 2008; 4(2): 96-109.
[http://dx.doi.org/10.1016/j.jalz.2007.08.005] [PMID: 18631955]
[41]
Burns A, Brayne C, Folstein M. The mini-mental state examination, will we be using it in 2001? Int J Geriatr Psychiatry 1998; 13(5): 285-94.
[http://dx.doi.org/10.1002/(SICI)1099-1166(199805)13:5<285:AID-GPS753>3.0.CO;2-V] [PMID: 9658260]
[42]
Almeida OP. Mini mental state examination and the diagnosis of dementia in Brazil. Arq Neuropsiquiatr 1998; 56(3B): 605-12.
[http://dx.doi.org/10.1590/S0004-282X1998000400014] [PMID: 9850757]
[43]
Bertolucci PHF, Brucki SMD, Campacci SR, Juliano YO. The Mini-Mental State Examination in a general population: Impact of educational status. Arquivos de Neuro-Psiquiatria 1994; 52(1): 1-7.
[http://dx.doi.org/10.1590/S0004-282X1994000100001]
[44]
Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 2003; 61(3B): 777-81.
[http://dx.doi.org/10.1590/S0004-282X2003000500014] [PMID: 14595482]
[45]
Kochhann R, Varela JS, Lisboa CSM, Chaves MLF. The mini mental state examination: Review of cutoff points adjusted for schooling in a large Southern Brazilian sample. Dement Neuropsychol 2010; 4(1): 35-41.
[http://dx.doi.org/10.1590/S1980-57642010DN40100006] [PMID: 29213658]
[46]
Passos VMA, Giatti L, Bensenor I, Chor D, Barreto SM. Education plays a greater role than age in cognitive test performance among participants of the Brazilian longitudinal study of adult health (ELSA-Brasil). Int J Epidemiol 2015; 44 (Suppl. 1): i265-5.
[http://dx.doi.org/10.1093/ije/dyv096.503]
[47]
Alencar RC, Cobas RA, Gomes MB. Assessment of cognitive status in patients with type 2 diabetes through the mini-mental status examination: A cross-sectional study. Diabetol Metab Syndr 2010; 2(1): 10.
[http://dx.doi.org/10.1186/1758-5996-2-10] [PMID: 20205826]
[48]
Monteiro S, Torres A, Pereira A, Albuquerque E, Morgadinho R. Preliminary validation study of a Portuguese version of the patient health questionnaire (PHQ-9). Eur Psychiatry 2013; 28(S1): 1.
[http://dx.doi.org/10.1016/S0924-9338(09)71489-0]
[49]
Santos IS, Tavares BF, Munhoz TN, et al. Sensibilidade e especificidade do patient health questionnaire-9 (PHQ-9) entre adultos da população geral. Cad Saude Publica 2013; 29(8): 1533-43.
[http://dx.doi.org/10.1590/S0102-311X2013001200006] [PMID: 24005919]
[50]
Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, Toronto: Wiley 2000; p. 383.
[http://dx.doi.org/10.1002/0471722146]
[51]
Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol 2016; 4(6): 537-47.
[http://dx.doi.org/10.1016/S2213-8587(16)30010-9] [PMID: 27156051]
[52]
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018; 90(3): 126-35.
[http://dx.doi.org/10.1212/WNL.0000000000004826] [PMID: 29282327]
[53]
Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: A clinical review. JAMA 2014; 312(23): 2551-61.
[http://dx.doi.org/10.1001/jama.2014.13806] [PMID: 25514304]
[54]
Caamaño-Isorna F, Corral M, Montes-Martínez A, Takkouche B. Education and dementia: A meta-analytic study. Neuroepidemiology 2006; 26(4): 226-32.
[http://dx.doi.org/10.1159/000093378] [PMID: 16707907]
[55]
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020; 396(10248): 413-46.
[http://dx.doi.org/10.1016/S0140-6736(20)30367-6] [PMID: 32738937]
[56]
Díaz-Coránguez M, Ramos C, Antonetti DA. The inner blood-retinal barrier: Cellular basis and development. Vision Res 2017; 139: 123-37.
[http://dx.doi.org/10.1016/j.visres.2017.05.009] [PMID: 28619516]
[57]
Blazes M, Lee CS. Understanding the brain through aging eyes. Advances in Geriatric Medicine and Research 2021; 3(2): e210008.
[PMID: 33748826]
[58]
Zhao W-Q, Chen H, Quon MJ, Alkon DL. Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 2004; 490(1-3): 71-81.
[http://dx.doi.org/10.1016/j.ejphar.2004.02.045] [PMID: 15094074]
[59]
Ferrario CR, Reagan LP. Insulin-mediated synaptic plasticity in the CNS: Anatomical, functional and temporal contexts. Neuropharmacology 2018; 136(Pt B): 182-91.
[PMID: 29217283]
[60]
Chiu S-L, Chen C-M, Cline HT. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 2008; 58(5): 708-19.
[http://dx.doi.org/10.1016/j.neuron.2008.04.014] [PMID: 18549783]
[61]
Ko F, Muthy ZA, Gallacher J, et al. Association of retinal nerve fiber layer thinning with current and future cognitive decline: A study using optical coherence tomography. JAMA Neurol 2018; 75(10): 1198-205.
[http://dx.doi.org/10.1001/jamaneurol.2018.1578] [PMID: 29946685]
[62]
Khawaja AP, Chan MPY, Yip JLY, et al. Retinal nerve fiber layer measures and cognitive function in the EPIC-norfolk cohort study. Invest Ophthalmol Vis Sci 2016; 57(4): 1921-6.
[http://dx.doi.org/10.1167/iovs.16-19067] [PMID: 27092718]
[63]
van Dijk HW, Verbraak FD, Kok PHB, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010; 51(7): 3660-5.
[http://dx.doi.org/10.1167/iovs.09-5041] [PMID: 20130282]
[64]
Ponirakis G, Al Hamad H, Sankaranarayanan A, et al. Association of corneal nerve fiber measures with cognitive function in dementia. Ann Clin Transl Neurol 2019; 6(4): 689-97.
[http://dx.doi.org/10.1002/acn3.746] [PMID: 31019993]
[65]
Al-Janahi E, Ponirakis G, Al Hamad H, et al. Corneal nerve and brain imaging in mild cognitive impairment and dementia. J Alzheimers Dis 2020; 77(4): 1533-43.
[http://dx.doi.org/10.3233/JAD-200678] [PMID: 32925064]
[66]
Ponirakis G, Elsotouhy A, Al Hamad H, et al. Association of cerebral ischemia with corneal nerve loss and brain atrophy in MCI and dementia. Front Neurosci 2021; 15: 690896.
[http://dx.doi.org/10.3389/fnins.2021.690896] [PMID: 34234643]
[67]
Lee CS, Larson EB, Gibbons LE, et al. Associations between recent and established ophthalmic conditions and risk of Alzheimer’s disease. Alzheimers Dement 2019; 15(1): 34-41.
[http://dx.doi.org/10.1016/j.jalz.2018.06.2856] [PMID: 30098888]
[68]
Cheung CY, Ikram MK, Chen C, Wong TY. Imaging retina to study dementia and stroke. Prog Retin Eye Res 2017; 57: 89-107.
[http://dx.doi.org/10.1016/j.preteyeres.2017.01.001] [PMID: 28057562]
[69]
Naël V, Pérès K, Dartigues J-F, et al. Vision loss and 12-year risk of dementia in older adults: The 3C cohort study. Eur J Epidemiol 2019; 34(2): 141-52.
[http://dx.doi.org/10.1007/s10654-018-00478-y] [PMID: 30610413]
[70]
Shang X, Zhu Z, Wang W, Ha J, He M. The association between vision impairment and incidence of dementia and cognitive impairment: A systematic review and meta-analysis. Ophthalmology 2021; 128(8): 1135-49.
[http://dx.doi.org/10.1016/j.ophtha.2020.12.029] [PMID: 33422559]
[71]
Chen SP, Bhattacharya J, Pershing S. Association of vision loss with cognition in older adults. JAMA Ophthalmol 2017; 135(9): 963-70.
[http://dx.doi.org/10.1001/jamaophthalmol.2017.2838] [PMID: 28817745]
[72]
Paik J-S, Ha M, Jung YH, et al. Low vision and the risk of dementia: A nationwide population-based cohort study. Sci Rep 2020; 10(1): 9109.
[http://dx.doi.org/10.1038/s41598-020-66002-z] [PMID: 32499618]
[73]
Michalowsky B, Hoffmann W, Kostev K. Association between hearing and vision impairment and risk of dementia: Results of a case-control study based on secondary data. Front Aging Neurosci 2019; 11: 363.
[http://dx.doi.org/10.3389/fnagi.2019.00363] [PMID: 31920631]
[74]
Hong T, Mitchell P, Burlutsky G, Liew G, Wang JJ. Visual impairment, hearing loss and cognitive function in an older population: Longitudinal findings from the blue mountains eye study. PLoS One 2016; 11(1): e0147646.
[http://dx.doi.org/10.1371/journal.pone.0147646] [PMID: 26808979]
[75]
Wu M, Mei F, Hu K, et al. Diabetic retinopathy and cognitive dysfunction: A systematic review and meta-analysis. Acta Diabetol 2022; 59(4): 443-59.
[http://dx.doi.org/10.1007/s00592-021-01829-0] [PMID: 35112186]
[76]
Chai Y-H, Zhang Y-P, Qiao Y-S, et al. Association between diabetic retinopathy, brain structural abnormalities, and cognitive impairment for accumulated evidence in observational studies. Am J Ophthalmol 2022; 239: 37-53.
[http://dx.doi.org/10.1016/j.ajo.2022.01.011] [PMID: 35063409]

Rights & Permissions Print Cite